October 7, 2025
The LIVERATION clinical trial continues to gain momentum: we’ve now reached 171 randomized patients, and we’re pleased to welcome San Camillo Forlanini Hospital in Rome, which has joined the study with its first patient included.
With active centres in Spain, Italy, Slovenia, and Switzerland, the joint efforts of clinical and surgical teams are bringing us closer to our goal: reducing liver cancer recurrence after surgery.
Each participant brings us one step closer to improving outcomes for liver cancer patients across Europe.
